Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users - Wikidata - awgldk - TriplyDB

Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

http://www.wikidata.org/entity/Q37210189

about

Stereotypes, Prejudice, and Depression: The Integrated Perspective State of the art treatments for cannabis dependence Pharmacotherapy for cannabis dependence: how close are we?CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review Cannabinoid abuse and addiction: Clinical and preclinical findings Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction Opioid antagonism enhances marijuana's effects in heavy marijuana smokers Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats.Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature Pharmacological treatment of cannabis dependence.Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.Endocannabinoid signaling mediates oxytocin-driven social reward Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers Marijuana dependence: not just smoke and mirrors.[Pharmacological and psychosocial interventions for cannabis use disorders].Antagonist-elicited cannabis withdrawal in humans CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men Novel medications to treat addictive disorders Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.Screening Medications for the Treatment of Cannabis Use Disorder.The future of endocannabinoid-oriented clinical research after CB1 antagonists.Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists.Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users.Evidence-based Treatment Options in Cannabis Dependency.Endocannabinoids and the cardiovascular response to stress.Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.Novel Pharmacologic Approaches to Treating Cannabis Use Disorder.Assessing the value of the zebrafish conditioned place preference model for predicting human abuse potential.An Introduction to the Endogenous Cannabinoid System.Cannabinoid signaling in health and disease.[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.

P2860

Q22241781-6655B9D6-9F34-42CE-B9AB-6011C24A8684 Q24607810-AD53206E-E440-4C57-A3AC-3D213490F6A2 Q24648976-48BE4340-EB11-4CF4-8DF6-EA1465A24817 Q24649936-193D0B41-0539-408D-AE00-43D785524788 Q26746192-8ED007A1-F5FF-401C-AAE0-BD6E7FB059B3 Q26851944-E5440EAA-1C9C-454B-807D-C8C975587F99 Q27025612-3A4A98A4-BE23-4D14-A197-16567C36E200 Q28283718-7B31D354-B3CC-42B6-A18E-7ACA4A7FC5E3 Q34072888-781FCEC2-D9FB-4EC4-950A-F8321EDFF486 Q34168253-59FB8537-2ADC-46A0-ABCE-4211D2E70FA3 Q34197119-6BBACE4F-3320-488C-B86E-1C3EC39952C7 Q34199610-590E2244-21C3-48A5-9E3A-B986D18D9E1A Q34320289-FDBA8812-EEA1-4982-BFCE-213D8467DA05 Q34635342-3CB48ABA-6F76-4586-9B84-37CAB3569DFB Q35210350-D318F6EA-328B-457A-BEAC-642C886363BB Q35840095-E2629A25-EFDE-4DC3-8773-268375E83267 Q35962896-7777A9F8-76B7-40C2-B25A-14A115F19A3F Q36059911-FA2C50DE-327D-4302-9A8E-0EA262661345 Q36300201-BB091AE6-AD59-4C63-956D-457074E48443 Q36647095-7FC32609-EB89-470C-80EC-83E80FEF6299 Q36712200-697A2827-823D-4FF4-B2BF-398E88E8A534 Q36948826-333B5EF9-B363-4104-8DBF-2865103481EA Q37029517-7B8B66C1-7CDC-4D1F-B37C-95A223153C2D Q37029559-B7EDE962-05A3-4AAE-847A-518AEEAD0630 Q37029633-AC91176D-B47A-47E4-B447-0401BA83DE4B Q37086175-8CB8ECA2-B476-480A-8B30-2C4FB252F5AC Q37187618-CBB7DA9B-12CA-4B41-8A7C-794B44A5A4BC Q37226111-E23ECE38-9629-4938-A692-27B2831DF000 Q37266063-A650D103-6C2A-4087-B65D-3D76F84F81CC Q37317906-3B50C69F-BF0A-4AEB-B322-BFE0644CE6A5 Q37347537-E42E6571-021C-4BD4-A0C8-DA1C1C86FF0F Q37394240-119436D0-6397-4DFE-8918-C40F80B60DDB Q37396986-9DAB3B17-0292-42B4-B6D9-7D9DDE6250E5 Q37894978-ECCAE638-0ED5-4AAB-B11C-6F6D519556CF Q38060837-F757D5E5-1196-478D-A8DF-E49B41E2AE9F Q38222436-D9F0A9B1-5903-4D5D-A957-F3F9953971C7 Q38633249-6EF8CE11-904E-4CCE-BD02-585CF38183FA Q38677365-77E29DEC-938E-4789-8AA6-04D9648AE504 Q39163671-A64B53FF-57F0-4A34-A52C-386E81BC09F5 Q39283967-8054F425-6680-444B-A940-7DD4D75FF081

P2860

Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

http://www.wikidata.org/entity/Q37210189

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 July 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Single and multiple doses of r ...... annabis in male cannabis users

@en

Single and multiple doses of r ...... nnabis in male cannabis users.

@nl

type

label

Single and multiple doses of r ...... annabis in male cannabis users

@en

Single and multiple doses of r ...... nnabis in male cannabis users.

@nl

prefLabel

Single and multiple doses of r ...... annabis in male cannabis users

@en

Single and multiple doses of r ...... nnabis in male cannabis users.

@nl

P1433

Q37210189-58B3F1FA-1F94-4A7E-9CB3-95D73CE5C8E4

P1476

Q37210189-77BCEF64-AFD7-47A5-8424-6FA93761900D

P2093

Q37210189-2959C682-1DED-4C25-A9AC-769E44F07E9A

Q37210189-3706490B-E5A6-4383-B6E5-85CFA139E48B

Q37210189-4B34A3F5-786E-42A3-813F-F0BC18C49255

Q37210189-B8B4AE05-BF56-41B7-B341-1162CB470E74

Q37210189-CC6A9220-AD51-4569-ADFA-C99C07FB9B42

Q37210189-F240E908-F9E6-4C18-9413-231EA57B3923

P2860

Q37210189-09EA2016-0513-4E29-A3EF-2D8120BA8F6D

Q37210189-0D0A06A9-5AE0-45D3-8468-52D8886FB83D

Q37210189-0D3D6065-42A6-4F06-ADE8-CCD20460F176

Q37210189-0DBCAC48-46CF-4263-97E9-2702861E2483

Q37210189-173FC925-7F87-4609-BC46-A262A7DBBD4D

Q37210189-1A9196AF-2882-4DC9-9B55-491908EADB76

Q37210189-1D42B257-6DBD-441D-8020-803E6800B3CD

Q37210189-1D6990F2-ABCB-4484-9D20-085F47F44832

Q37210189-2D28043A-0594-4FD8-8A0C-5DC90E266DB5

Q37210189-30328A67-956D-4E3B-9BE1-EA120CFED2B6

P2888

Q37210189-8BAB65AA-3828-476D-981B-56DAA94F5F43

P304

Q37210189-482A05DF-CA88-41BC-87F5-0BF229DC68CA

P31

Q37210189-698FB851-4208-4324-8D54-61428971D688

P356

Q37210189-CD6277C5-9C60-48CA-9586-2B9D47A7E1A2

P433

Q37210189-C9800DD2-DFAA-4ACB-8777-FBC51E2958E4

P478

Q37210189-8FAFEDA4-8E63-4B2C-9BC3-BF5EEB561059

P50

Q37210189-0E1AA9D7-02B2-4C74-A916-02FCD1759CFC

P577

Q37210189-26B1BD61-93CC-4469-A041-61BAF9704996

P5875

Q37210189-572EF7E8-0FAF-4EF8-8C65-F4D4EE69FF1C

P698

Q37210189-A64537C7-487D-41A9-B03A-A937EE090B7C

P932

Q37210189-2DF0599B-8FD6-43BB-B492-2ADBEC31274F

P356

S00213-007-0861-5

P1433

Psychopharmacology

P1476

Single and multiple doses of r ...... annabis in male cannabis users

@en

P2093

David A Gorelick

http://www.w3.org/2001/XMLSchema#string

Denis Bonnet

http://www.w3.org/2001/XMLSchema#string

Gerard Le Fur

http://www.w3.org/2001/XMLSchema#string

Kenzie L Preston

http://www.w3.org/2001/XMLSchema#string

Stephen J Heishman

http://www.w3.org/2001/XMLSchema#string

Susan J Boyd

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure

Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716

Leptin-regulated endocannabinoids are involved in maintaining food intake

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

Behavioral effects of cannabinoid agents in animals.

P2888

s00213-007-0861-5

P304

505-515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-007-0861-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

194

http://www.w3.org/2001/XMLSchema#string

P50

Marilyn Huestis

P577

2007-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6217782

http://www.w3.org/2001/XMLSchema#string

P698

17619859

http://www.w3.org/2001/XMLSchema#string

P932

2689519

http://www.w3.org/2001/XMLSchema#string